BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7426949)

  • 1. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R; Khoury S; Richard F; Fourcade F; Frantz P; Capelle JP
    Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Fosså SD; Miller A
    J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T; Jonsson G
    J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 7. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L; Edsmyr F; Jönsson G; Könyves I
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 9. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
    Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
    Benson RC; Wear JB; Gill GM
    J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R; Mittelman A; Kaufman J; Murphy GP
    N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R; Köllin CP
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F; Kisbenedek L
    Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A; Shukla SK; Murphy GP
    J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD; Fosså J; Aakvaag A
    J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A; Shukla SK; Welvaart K; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):219-23. PubMed ID: 1093669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.